相关实验视频

Updated: Jan 11, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

直接口服抗凝剂治疗的安全性和最佳使用

Claudio Laudani^1,2, Luis Ortega-Paz², Ali Zgheib²

¹Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "Rodolico - San Marco", University of Catania, Catania, Italy.

Expert opinion on drug safety

|November 10, 2025

概括

直接口服抗凝剂 (DOAC) 已经改变了口服抗凝剂 (OAC) 治疗,比较旧的治疗方法提供了更好的安全性和有效性. 需要进一步的研究,以解决OAC治疗优化的未满足需求.

科学领域:

药理学药理学是指药理学的学科.
心脏病学心脏病学
血液学血液学血液学

背景情况:

直接口服抗凝剂 (DOAC) 代表了抗凝剂治疗的重大进展,克服了与维生素K对抗剂相关的局限性.
DOAC 已成为管理各种血栓栓塞状况的基石.

研究的目的:

审查可用的DOACs的药理动力学和药理动力学概况.
评估DOAC在关键临床适应症中的有效性和安全性.
为了确定当前在DOAC治疗中的局限性和未满足的需求.

主要方法:

对apixaban,rivaroxaban,dabigatran和edoxaban的药理动力学和药理动力学数据的综合文献综述.
对临床试验数据的分析,评估心房动,静脉血栓栓塞,癌症相关血栓症和动脉样硬化疾病中的DOAC.
评估安全性和有效性概况,包括出血事件和血栓结局.

主要成果:

DOAC 具有独特的药理动力学和药理动力学特性,影响其临床应用.
证据支持DOACs在主要适应症中的疗效和安全性,通常显示非劣势或优于传统抗凝剂.
特定的患者群体和临床场景可能仍然对当前的DOACs构成挑战.

结论:

DOACs已经彻底改变了OAC治疗,具有良好的安全性和有效性.
尽管取得了进展,但仍然存在未得到满足的需求,这凸显了持续研究的必要性.
优化DOAC的使用需要对其在各种临床环境中的应用进行持续调查.

关键词:

直接的口服抗凝剂直接的口服抗凝剂心房动是心房动的一种.冠状动脉疾病是一种冠状动脉疾病.静脉血栓塞栓症是一种静脉血栓塞栓.维生素K的对抗者.

更多相关视频

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...